Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Piotr Adamowicz. (2021) Blood concentrations of synthetic cannabinoids. Clinical Toxicology 59:3, pages 246-251.
Read now
Read now
Maria Paneta & William Stephen Waring. (2019) Literature review of the evidence regarding intravenous lipid administration in drug-induced cardiotoxicity. Expert Review of Clinical Pharmacology 12:7, pages 591-602.
Read now
Read now
Rachelle Abouchedid, Simon Hudson, Natalie Thurtle, Takahiro Yamamoto, James H. Ho, George Bailey, Michelle Wood, Nele Sadones, Christophe P. Stove, Alison Dines, John R. H. Archer, David M. Wood & Paul I. Dargan. (2017) Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015 . Clinical Toxicology 55:5, pages 338-345.
Read now
Read now
Michael Levine, Robert S. Hoffman, Valéry Lavergne, Christine M. Stork, Andis Graudins, Ryan Chuang, Samuel J. Stellpflug, Martin Morris, Andrea Miller-Nesbitt & Sophie Gosselin. (2016) Systematic review of the effect of intravenous lipid emulsion therapy for non-local anesthetics toxicity. Clinical Toxicology 54:3, pages 194-221.
Read now
Read now
Robert J. Tait, David Caldicott, David Mountain, Simon L. Hill & Simon Lenton. (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology 54:1, pages 1-13.
Read now
Read now
Marisol S. Castaneto, Ariane Wohlfarth, Nathalie A. Desrosiers, Rebecca L. Hartman, David A. Gorelick & Marilyn A. Huestis. (2015) Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metabolism Reviews 47:2, pages 124-174.
Read now
Read now
Articles from other publishers (44)
Mariana Campello de Oliveira, Mariana Capelo Vides, Dângela Layne Silva Lassi, Julio Torales, Antonio Ventriglio, Henrique Silva Bombana, Vilma Leyton, Cintia de Azevedo-Marques Périco, André Brooking Negrão, André Malbergier & João Maurício Castaldelli-Maia. (2023) Toxicity of Synthetic Cannabinoids in K2/Spice: A Systematic Review. Brain Sciences 13:7, pages 990.
Crossref
Crossref
Catheryn D. Wilson, Fang Zheng & William E. Fantegrossi. (2022) Convulsant doses of abused synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA and JWH-018 do not elicit electroencephalographic (EEG) seizures in male mice. Psychopharmacology 239:10, pages 3237-3248.
Crossref
Crossref
Eric Sparkes, Elizabeth A. Cairns, Richard C. Kevin, Felcia Lai, Katharina Elisabeth Grafinger, Shuli Chen, Marie H. Deventer, Ross Ellison, Rochelle Boyd, Lewis J. Martin, Iain S. McGregor, Roy R. Gerona, David E. Hibbs, Volker Auwärter, Michelle Glass, Christophe Stove & Samuel D. Banister. (2022)
Structure–activity relationships of valine,
tert
-leucine, and phenylalanine amino acid-derived synthetic cannabinoid receptor agonists related to ADB-BUTINACA, APP-BUTINACA, and ADB-P7AICA
. RSC Medicinal Chemistry 13:2, pages 156-174.
Crossref
Crossref
Michael Collins. (2021) Synthetic Cannabinomimetics: A Brief History and the Challenges They Pose for the Forensic Chemist. Australian Journal of Chemistry 74:6, pages 405-415.
Crossref
Crossref
Nahla E. Nagy, Mahmoud M. Elhabiby, Nesreen M. Mohsen, Lobna A.B. Ismail & Samar W. Farouk. (2021) Relation Between Acute Administration of Synthetic Cannabinoids and Induction of Epileptic Seizures. Addictive Disorders & Their Treatment 20:4, pages 527-534.
Crossref
Crossref
Ahna Brutlag. 2021. Cannabis Therapy in Veterinary Medicine. Cannabis Therapy in Veterinary Medicine
61
83
.
Adam Worob & Cody Wenthur. (2019) DARK Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice/K2). ACS Chemical Neuroscience 11:23, pages 3881-3892.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Andrea Ossato, Claudio Trapella, Giovanni Serpelloni, Margherita Neri, Liana Fattore & Matteo Marti. (2020) Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice. NeuroToxicology 76, pages 17-32.
Crossref
Crossref
Efrat Kelmer, Jakob A. Shimshoni, Yael Merbl, Ofer Kolski & Sigal Klainbart. (2019) Use of gas chromatography–mass spectrometry for definitive diagnosis of synthetic cannabinoid toxicity in a dog. Journal of Veterinary Emergency and Critical Care 29:5, pages 573-577.
Crossref
Crossref
Richard C. Kevin, Lyndsey Anderson, Iain S. McGregor, Rochelle Boyd, Jamie J. Manning, Michelle Glass, Mark Connor & Samuel D. Banister. (2019) CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist. Frontiers in Pharmacology 10.
Crossref
Crossref
Abdulsallam Bakdash, Ahmad Mohamed Khir AL-Mathloum, Elkhatim H. Abdelgadir ElAmin, Nael M. T. Abu Taha, Sachil Kumar & Fahd Ali Nasr. (2018) Single-dose acute toxicity of THJ-2201 designer Cannabis drug: LD50 and hematological and histological changes in mice. Egyptian Journal of Forensic Sciences 8:1.
Crossref
Crossref
Ahna Brutlag & Holly Hommerding. (2018) Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats. Veterinary Clinics of North America: Small Animal Practice 48:6, pages 1087-1102.
Crossref
Crossref
Nicola Bates. (2018) Exposure to drugs of abuse. Companion Animal 23:2, pages 73-80.
Crossref
Crossref
Simon L Hill, Michael Dunn, Céline Cano, Suzannah J Harnor, Ian R Hardcastle, Johann Grundlingh, Paul I Dargan, David M Wood, Simon Tucker, Thomas Bartram & Simon H L Thomas. (2018) Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification. Clinical Chemistry 64:2, pages 346-354.
Crossref
Crossref
Masahiko Funada & Mika Takebayashi-Ohsawa. (2018) Synthetic cannabinoid AM2201 induces seizures: Involvement of cannabinoid CB 1 receptors and glutamatergic transmission. Toxicology and Applied Pharmacology 338, pages 1-8.
Crossref
Crossref
Samuel D. Banister & Mark Connor. 2018. New Psychoactive Substances. New Psychoactive Substances
191
226
.
Aviv M. Weinstein, Paola Rosca, Liana Fattore & Edythe D. London. (2017) Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health. Frontiers in Psychiatry 8.
Crossref
Crossref
Francois R. Lamy, Raminta Daniulaityte, Ramzi W. Nahhas, Monica J. Barratt, Alan G. Smith, Amit Sheth, Silvia S. Martins, Edward W. Boyer & Robert G. Carlson. (2017) Increases in synthetic cannabinoids-related harms: Results from a longitudinal web-based content analysis. International Journal of Drug Policy 44, pages 121-129.
Crossref
Crossref
Isabella Canazza, Andrea Ossato, Fabrizio Vincenzi, Adolfo Gregori, Fabiana Di Rosa, Federica Nigro, Alessandro Rimessi, Paolo Pinton, Katia Varani, Pier Andrea Borea & Matteo Marti. (2017) Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2601.
Crossref
Crossref
Benjamin M. Ford, Sherrica Tai, William E. Fantegrossi & Paul L. Prather. (2017) Synthetic Pot: Not Your Grandfather’s Marijuana. Trends in Pharmacological Sciences 38:3, pages 257-276.
Crossref
Crossref
Neil A. Patel, Jason M. Jerry, Xavier F. Jimenez & Stephen T. Hantus. (2017) New-Onset Refractory Status Epilepticus Associated With the Use of Synthetic Cannabinoids. Psychosomatics 58:2, pages 180-186.
Crossref
Crossref
Colin Davidson, Jolanta Opacka-Juffry, Angel Arevalo-Martin, Daniel Garcia-Ovejero, Eduardo Molina-Holgado & Francisco Molina-Holgado. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
135
168
.
D. French. 2017.
153
198
.
A. Helander. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
839
847
.
Philippe E. Hantson. 2017. Critical Care Toxicology. Critical Care Toxicology
447
473
.
Annelies Cannaert, Jolien Storme, Florian Franz, Volker Auwärter & Christophe P. Stove. (2016) Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites with a Newly Developed Bioassay. Analytical Chemistry 88:23, pages 11476-11485.
Crossref
Crossref
Rachelle Abouchedid, James H. Ho, Simon Hudson, Alison Dines, John R. H. Archer, David M. Wood & Paul I. Dargan. (2016) Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation. Journal of Medical Toxicology 12:4, pages 396-401.
Crossref
Crossref
Isabella Canazza, Andrea Ossato, Claudio Trapella, Anna Fantinati, Maria Antonietta De Luca, Giulia Margiani, Fabrizio Vincenzi, Claudia Rimondo, Fabiana Di Rosa, Adolfo Gregori, Katia Varani, Pier Andrea Borea, Giovanni Serpelloni & Matteo Marti. (2016) Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on ?tetrad?, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Psychopharmacology 233:21-22, pages 3685-3709.
Crossref
Crossref
David M. Wood & Paul I. Dargan. 2016. Current Practice in Forensic Medicine. Current Practice in Forensic Medicine
35
46
.
Andrej Grigoryev, Pierce Kavanagh & Alexandr Pechnikov. (2016) Human urinary metabolite pattern of a new synthetic cannabimimetic, methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate. Forensic Toxicology 34:2, pages 316-328.
Crossref
Crossref
Yuji Fujita, Atsuhiko Koeda, Yasuhisa Fujino, Makoto Onodera, Satoshi Kikuchi, Hisae Niitsu, Yasumasa Iwasaki, Kiyotaka Usui & Yoshihiro Inoue. (2016) Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones. Acute Medicine & Surgery 3:3, pages 230-236.
Crossref
Crossref
Abdulaziz A. Aldlgan & Hazel J. Torrance.. (2016) Bioanalytical methods for the determination of synthetic cannabinoids and metabolites in biological specimens. TrAC Trends in Analytical Chemistry 80, pages 444-457.
Crossref
Crossref
Michael B. Gatch & Michael J. Forster. (2016) Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids in mice and rats. Psychopharmacology 233:10, pages 1901-1910.
Crossref
Crossref
Liana Fattore. (2016) Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry 79:7, pages 539-548.
Crossref
Crossref
Daniel Castellanos. (2016) Synthetic cannabinoids 2015: An update for pediatricians in clinical practice. World Journal of Clinical Pediatrics 5:1, pages 16.
Crossref
Crossref
C. Hess, S. Stockhausen, G. Kernbach-Wighton & B. Madea. (2015) Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids?. Forensic Science International 257, pages e6-e11.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
Samuel D. Banister, Jordyn Stuart, Richard C. Kevin, Amelia Edington, Mitchell Longworth, Shane M. Wilkinson, Corinne Beinat, Alexandra S. Buchanan, David E. Hibbs, Michelle Glass, Mark Connor, Iain S. McGregor & Michael Kassiou. (2015) Effects of Bioisosteric Fluorine in Synthetic Cannabinoid Designer Drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. ACS Chemical Neuroscience 6:8, pages 1445-1458.
Crossref
Crossref
Michael B. Gatch & Michael J. Forster. (2015) Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market. Behavioural Pharmacology 26:5, pages 460-468.
Crossref
Crossref
A. Ossato, A. Vigolo, C. Trapella, C. Seri, C. Rimondo, G. Serpelloni & M. Marti. (2015) JWH-018 impairs sensorimotor functions in mice. Neuroscience 300, pages 174-188.
Crossref
Crossref
A. Vigolo, A. Ossato, C. Trapella, F. Vincenzi, C. Rimondo, C. Seri, K. Varani, G. Serpelloni & M. Marti. (2015) Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice. Neuropharmacology 95, pages 68-82.
Crossref
Crossref
István Katona. 2015. Endocannabinoids. Endocannabinoids
285
316
.
Philippe E. Hantson. 2016. Critical Care Toxicology. Critical Care Toxicology
1
27
.